E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 

Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each.


Click on the deal summary to see the full details.

Eli Lilly & Co. 4.500% due 2/9/2027

Eli Lilly & Co. 4.500% due 2/9/2029

Eli Lilly & Co. 4.700% due 2/9/2034

Eli Lilly & Co. 5.000% due 2/9/2054

Eli Lilly & Co. 5.100% due 2/9/2064

Eli Lilly & Co. 5.000% due 2/27/2026

Eli Lilly & Co. 4.700% due 2/27/2033

Eli Lilly & Co. 4.875% due 2/27/2053

Eli Lilly & Co. 4.950% due 2/27/2063

Eli Lilly & Co. 0.500% due 9/14/2033

Eli Lilly & Co. 2.250% due 5/15/2050

Eli Lilly & Co. 2.500% due 9/15/2060

Eli Lilly & Co. 2.250% due 5/15/2050

Eli Lilly & Co. 3.375% due 3/15/2029

Eli Lilly & Co. 3.875% due 3/15/2039

Eli Lilly & Co. 3.950% due 3/15/2049

Eli Lilly & Co. 4.150% due 3/15/2059

Eli Lilly & Co. 2.350% due 5/15/2022

Eli Lilly & Co. 3.100% due 5/15/2027

Eli Lilly & Co. 3.950% due 5/15/2047

Eli Lilly & Co. 1.250% due 3/1/2018

Eli Lilly & Co. 2.750% due 6/1/2025

Eli Lilly & Co. 3.700% due 3/1/2045

Eli Lilly & Co. 1.950% due 3/15/2019

Eli Lilly & Co. 4.650% due 6/15/2044

Eli Lilly & Co. 3.550% due 3/6/2012

Eli Lilly & Co. 4.200% due 3/6/2014

Eli Lilly & Co. 5.950% due 3/6/2037

Eli Lilly & Co. Floating due 9/1/2006



© 2012 Prospect News.
All content in this database is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.